G R Corazza
Overview
Explore the profile of G R Corazza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
3312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Fina D, Franze E, Rovedatti L, Corazza G, Biancone L, Sileri P, et al.
Mucosal Immunol
. 2010 Oct;
4(2):239-44.
PMID: 20944558
An altered balance between effector and regulatory factors is supposed to sustain the tissue-damaging immune response in inflammatory bowel disease (IBD). We have recently shown that in IBD, there is...
22.
Ciccocioppo R, Finamore A, Mengheri E, Millimaggi D, Esslinger B, Dieterich W, et al.
Int J Immunopathol Pharmacol
. 2010 Apr;
23(1):179-91.
PMID: 20377989
Tissue transglutaminase (TG2) was identified as the humoral autoantigen in coeliac disease, but whether it can also serve as T cell autoantigen is still unknown. We aimed, therefore, to firstly...
23.
Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles C, Rampton D, et al.
Gut
. 2009 Sep;
58(12):1629-36.
PMID: 19740775
Background And Aims: Interleukin 17 (IL17) is now known to be involved in a number of chronic inflammatory disorders. However, the mechanisms regulating its production in inflammatory bowel disease (IBD)...
24.
Versino M, Franciotta D, Colnaghi S, Biagi F, Zardini E, Bianchi P, et al.
Neurology
. 2009 Jun;
72(23):2046-8.
PMID: 19506229
No abstract available.
25.
Gasbarrini A, Corazza G, Gasbarrini G, Montalto M, di Stefano M, Basilisco G, et al.
Aliment Pharmacol Ther
. 2009 Apr;
29 Suppl 1:1-49.
PMID: 19344474
Background: Breath tests represent a valid and non-invasive diagnostic tool in many gastroenterological conditions. The rationale of hydrogen-breath tests is based on the concept that part of the gas produced...
26.
di Sabatino A, Jackson C, Pickard K, Buckley M, Rovedatti L, Leakey N, et al.
Gut
. 2009 Feb;
58(6):777-89.
PMID: 19201776
Background And Aims: In addition to its crucial role in dampening tissue-damaging immune responses in the gut, transforming growth factor beta (TGFbeta) is a potent profibrogenic agent inducing collagen synthesis...
27.
Gobbi P, Valentino F, Lambelet P, Perfetti V, Bergamaschi G, Girino M, et al.
Bone Marrow Transplant
. 2009 Jan;
44(1):19-25.
PMID: 19139733
There is great interest in chemotherapies for relapsed or refractory lymphomas that are both directly effective against the lymphoma and able to mobilize PBSCs for rescue after high-dose chemotherapy (HDC)....
28.
Gobbi P, Corbella F, Valentino F, Bergonzi M, Sangalli C, Perfetti V, et al.
Ann Oncol
. 2008 Dec;
20(3):465-8.
PMID: 19074214
Background: The optimal approach to patients with gastric lymphoma of extranodal mucosa-associated lymphoid tissue (MALT) that resist to anti-Helicobacter pylori (HP) eradication therapy is still to be defined. Patients And...
29.
di Stefano M, Terulla V, Tana P, Mazzocchi S, Romero E, Corazza G
Dig Liver Dis
. 2008 Nov;
41(7):474-9.
PMID: 19010095
Background: Adult-type hypolactasia is a widespread condition throughout the world, causing lactose malabsorption. The lactose breath test is a simple tool for diagnosis but the need for prolonged monitoring of...
30.
Biagi F, Bianchi P, Campanella J, Badulli C, Martinetti M, Klersy C, et al.
J Clin Pathol
. 2008 Aug;
61(10):1116-8.
PMID: 18708422
Aims: Although they are non-specific, minimal intestinal lesions are at the end of the coeliac histological damage spectrum. To investigate whether minimal intestinal lesions in patients without endomysial antibodies are...